Andreas Rimner, MD

home / authors / andreas-rimner-md

Articles

Andreas Rimner, MD, on Immunotherapy Combined with Radiation in Lung Cancer

November 25th 2019

The radiation oncologist from Memorial Sloan Kettering Cancer Center, discusses several ongoing trials combining immunotherapy and radiation at the 14th Annual New York Lung Cancers Symposium®.

ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent

Joe Yujiao Chang, MD, PhD;Larry L. Kestin, MD;R. Bryan Barriger, MD;Indrin J. Chetty, PhD;Mark E. Ginsburg, MD;Sanath Kumar, MD;Billy W. Loo, Jr, MD, PhD;Benjamin Movsas, MD;Andreas Rimner, MD;Kenneth E. Rosenzweig, MD;Thomas E. Stinchcombe, MD;Gregory M. M. Videtic, MD, CM;Henning Willers, MD

August 15th 2014

The treatment of inoperable stage III non–small-cell lung cancer (NSCLC) remains a challenge due to high rates of distant metastasis, local recurrence, and toxicity associated with definitive therapy.